Landscapes / Targets
ANGPTL3
5 drugs act on ANGPTL3, in 7 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs5
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Monoclonal antibody |
Regeneron · Public REGN |
Approved | 13 Oct 2028Phase 2 trial completes | ||
| How it works | An antibody | ||||
| Next date | 13 Oct 2028 · Phase 2 trial completes | ||||
| Also tested for | Diabetic Kidney Disease (DKD) | ||||
| Open drug page | |||||
Small interfering RNA |
Arrowhead · Public ARWR |
Phase 3 | 20 Aug 2027Phase 3 trial completes | ||
| How it works | A short strand of RNA that switches off one gene | ||||
| Next date | 20 Aug 2027 · Phase 3 trial completes | ||||
| Also tested for | Homozygous Familial Hypercholesterolemia | ||||
| Open drug page | |||||
— |
Phase 3 | — | |||
| Also tested for | Homozygous Familial Hypercholesterolemia (HoFH) | ||||
| Open drug page | |||||
— |
Phase 2 | Nov 2027Phase 2 trial completes | |||
| Next date | Nov 2027 · Phase 2 trial completes | ||||
| Also tested for | Homozygous Familial Hypercholesterolemia (HoFH), Mixed Dyslipidemia | ||||
| Open drug page | |||||
— |
Eli Lilly · Public LLY |
Phase 1 | Dec 2027Phase 1 trial completes | ||
| Next date | Dec 2027 · Phase 1 trial completes | ||||
| Also tested for | Hypercholesterolemia, Hypertriglyceridemia and 1 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 5 of 5 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026